Praneeth Reddy Keesari

407 total citations
20 papers, 78 citations indexed

About

Praneeth Reddy Keesari is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Praneeth Reddy Keesari has authored 20 papers receiving a total of 78 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Immunology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Praneeth Reddy Keesari's work include COVID-19 and healthcare impacts (3 papers), CAR-T cell therapy research (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Praneeth Reddy Keesari is often cited by papers focused on COVID-19 and healthcare impacts (3 papers), CAR-T cell therapy research (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Praneeth Reddy Keesari collaborates with scholars based in United States, India and United Kingdom. Praneeth Reddy Keesari's co-authors include Charan Thej Reddy Vegivinti, Rupak Desai, Nandini Ramachandra, Aditi Shastri, M Bakri Hammami, Sri Harsha Tella, Terenig Terjanian, Bharat Guthikonda, Gale Gardner and Catarina Maia and has published in prestigious journals such as Journal of Clinical Oncology, Blood and CHEST Journal.

In The Last Decade

Praneeth Reddy Keesari

15 papers receiving 75 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Praneeth Reddy Keesari United States 6 39 25 20 15 11 20 78
Charan Thej Reddy Vegivinti United States 6 33 0.8× 22 0.9× 25 1.3× 6 0.4× 33 3.0× 27 109
Jan‐Michel Heger Germany 6 56 1.4× 9 0.4× 15 0.8× 12 0.8× 3 0.3× 23 82
Raimundo García‐Boyero Spain 6 51 1.3× 20 0.8× 36 1.8× 18 1.2× 23 2.1× 7 101
Xiaobi Huang United States 5 21 0.5× 40 1.6× 6 0.3× 17 1.1× 15 1.4× 17 113
José Refugio Torres‐Nava Mexico 6 23 0.6× 18 0.7× 14 0.7× 13 0.9× 4 0.4× 9 68
Maxi Wass Germany 4 24 0.6× 15 0.6× 30 1.5× 6 0.4× 18 1.6× 7 74
Sarbajit Mukherjee United States 6 60 1.5× 17 0.7× 13 0.7× 10 0.7× 4 0.4× 19 114
Julius C. Enßle Germany 5 17 0.4× 47 1.9× 23 1.1× 8 0.5× 8 0.7× 12 78
Mika Kohri Japan 7 58 1.5× 20 0.8× 25 1.3× 9 0.6× 4 0.4× 19 106
Elsa Miekoutima France 4 38 1.0× 65 2.6× 77 3.9× 9 0.6× 23 2.1× 5 143

Countries citing papers authored by Praneeth Reddy Keesari

Since Specialization
Citations

This map shows the geographic impact of Praneeth Reddy Keesari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Praneeth Reddy Keesari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Praneeth Reddy Keesari more than expected).

Fields of papers citing papers by Praneeth Reddy Keesari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Praneeth Reddy Keesari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Praneeth Reddy Keesari. The network helps show where Praneeth Reddy Keesari may publish in the future.

Co-authorship network of co-authors of Praneeth Reddy Keesari

This figure shows the co-authorship network connecting the top 25 collaborators of Praneeth Reddy Keesari. A scholar is included among the top collaborators of Praneeth Reddy Keesari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Praneeth Reddy Keesari. Praneeth Reddy Keesari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keesari, Praneeth Reddy, et al.. (2025). Navigating the Economic Burden of Multiple Myeloma: Insights into Cost-effectiveness of CAR-T and Bispecific Antibody Therapies. Current Hematologic Malignancy Reports. 20(1). 3–3. 1 indexed citations
2.
Keesari, Praneeth Reddy, Charan Thej Reddy Vegivinti, Chitra Hosing, et al.. (2025). Epidemiology, racial-socioeconomic disparities, and outcomes of T-cell prolymphocytic leukemia: A comprehensive analysis of the SEER database (2000-2021).. Journal of Clinical Oncology. 43(16_suppl).
3.
Keesari, Praneeth Reddy, et al.. (2024). Long-Term Risk of Colorectal Cancer in Patients With Prediabetes: A Comprehensive Systematic Review and Meta-Analysis. Journal of Gastrointestinal and Liver Diseases. 33(3). 386–393. 2 indexed citations
4.
Keesari, Praneeth Reddy, et al.. (2024). ACUTE PNEUMONITIS UNMASKED: A RARE CASE OF PEMBROLIZUMAB-INDUCED PULMONARY COMPLICATION. CHEST Journal. 166(4). A1959–A1960. 1 indexed citations
5.
Keesari, Praneeth Reddy, et al.. (2024). Pancreatic Cancer Risk in Prediabetes. Pancreas. 54(1). e51–e56. 4 indexed citations
6.
Keesari, Praneeth Reddy, Fouad Sakr, Samantha Lee, et al.. (2024). Unveiling the Hidden Stroke Threat in Patients With Atrial Fibrillation and Primary Hyperparathyroidism. The American Journal of Cardiology. 218. 94–101.
7.
Keesari, Praneeth Reddy, et al.. (2024). Vitamin B12 deficiency in dialysis patients: risk factors, diagnosis, complications, and treatment: A comprehensive review. World Journal of Nephrology. 13(4). 100268–100268. 3 indexed citations
8.
Keesari, Praneeth Reddy, et al.. (2024). Beyond Midostaurin: Role of Avapritinib in Managing Systemic Mastocytosis. Cureus. 16(5). e60161–e60161. 1 indexed citations
9.
Keesari, Praneeth Reddy, et al.. (2023). A Meta-Analysis of Randomized Clinical Trials Assessing the Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer. Current Oncology. 30(10). 9262–9275. 5 indexed citations
10.
Hardy, Nicole, et al.. (2023). Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis. Clinical and Experimental Medicine. 23(6). 1945–1959. 13 indexed citations
11.
Vegivinti, Charan Thej Reddy, Praneeth Reddy Keesari, Catarina Maia, et al.. (2023). Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review. Experimental Hematology and Oncology. 12(1). 60–60. 17 indexed citations
12.
Keesari, Praneeth Reddy, et al.. (2023). Association between prediabetes and breast cancer: a comprehensive meta-analysis. Breast Cancer Research and Treatment. 204(1). 1–13. 5 indexed citations
13.
Keesari, Praneeth Reddy, et al.. (2023). RDW As a Predictor of Adverse Outcomes: A Systematic Review and Meta-Analysis of Frailty and Mortality Risk. Blood. 142(Supplement 1). 5216–5216.
14.
Vegivinti, Charan Thej Reddy, Lawrence Liu, Praneeth Reddy Keesari, et al.. (2023). Efficacy of Bispecific Antibodies Vs CAR-T in the Treatment of Extramedullary Disease and High-Risk Cytogenetics in Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis. Blood. 142(Supplement 1). 1994–1994. 8 indexed citations
15.
Keesari, Praneeth Reddy, et al.. (2023). S4141 Immunotherapy-Induced Isolated Gastritis in a Tonsillar Cancer Case. The American Journal of Gastroenterology. 118(10S). S2622–S2623.
16.
Vegivinti, Charan Thej Reddy, et al.. (2022). Meta-Analysis on Impact of Rituximab in Patients with Hematological Malignancies with Covid-19 Infection. Blood. 140(Supplement 1). 13189–13190. 1 indexed citations
17.
Vegivinti, Charan Thej Reddy, et al.. (2022). Mortality of COVID-19 in Patients with Hematological Malignancies Versus Solid Tumors: A Systematic Literature Review and Meta-Analysis. Blood. 140(Supplement 1). 13218–13219. 1 indexed citations
18.
19.
Keesari, Praneeth Reddy, et al.. (2021). Epidemiology and Outcomes of Hospitalizations Due to Hepatocellular Carcinoma. Cureus. 13(12). e20089–e20089. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charan Thej Reddy Vegivinti Breakdown of academic impact, for papers by Jan‐Michel Heger Breakdown of academic impact, for papers by Raimundo García‐Boyero Breakdown of academic impact, for papers by Xiaobi Huang Breakdown of academic impact, for papers by José Refugio Torres‐Nava Breakdown of academic impact, for papers by Maxi Wass Breakdown of academic impact, for papers by Sarbajit Mukherjee Breakdown of academic impact, for papers by Julius C. Enßle Breakdown of academic impact, for papers by Mika Kohri Breakdown of academic impact, for papers by Elsa Miekoutima
Rankless by CCL
2026